litlas
ログインアカウント作成

Michael S. Ewer

1980–2023 年に発表

58
論文数
19,368
被引用数
52
h 指数
58
i10 指数

被引用数

Michael S. Ewer の年別被引用数1980 年: 被引用 1 件1982 年: 被引用 2 件1983 年: 被引用 8 件1984 年: 被引用 7 件1985 年: 被引用 9 件1986 年: 被引用 2 件1987 年: 被引用 12 件1988 年: 被引用 7 件1989 年: 被引用 13 件1990 年: 被引用 4 件1991 年: 被引用 6 件1992 年: 被引用 10 件1993 年: 被引用 12 件1994 年: 被引用 13 件1995 年: 被引用 7 件1996 年: 被引用 10 件1997 年: 被引用 14 件1998 年: 被引用 22 件1999 年: 被引用 32 件2000 年: 被引用 32 件2001 年: 被引用 34 件2002 年: 被引用 34 件2003 年: 被引用 27 件2004 年: 被引用 60 件2005 年: 被引用 81 件2006 年: 被引用 97 件2007 年: 被引用 142 件2008 年: 被引用 146 件2009 年: 被引用 132 件2010 年: 被引用 179 件2011 年: 被引用 123 件2012 年: 被引用 151 件2013 年: 被引用 167 件2014 年: 被引用 136 件2015 年: 被引用 182 件2016 年: 被引用 223 件2017 年: 被引用 177 件2018 年: 被引用 179 件2019 年: 被引用 547 件2020 年: 被引用 562 件2021 年: 被引用 451 件2022 年: 被引用 470 件2023 年: 被引用 279 件2024 年: 被引用 407 件2025 年: 被引用 203 件1981 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,549 件、この内訳の 26.9%中国: 引用元論文 459 件、この内訳の 8%イタリア: 引用元論文 402 件、この内訳の 7%イギリス: 引用元論文 333 件、この内訳の 5.8%ドイツ: 引用元論文 251 件、この内訳の 4.3%カナダ: 引用元論文 246 件、この内訳の 4.3%オランダ: 引用元論文 183 件、この内訳の 3.2%フランス: 引用元論文 170 件、この内訳の 2.9%スペイン: 引用元論文 166 件、この内訳の 2.9%ベルギー: 引用元論文 139 件、この内訳の 2.4%日本: 引用元論文 134 件、この内訳の 2.3%オーストラリア: 引用元論文 133 件、この内訳の 2.3%
0%26.9%その他 27.7%

機関

分野

  • Medicine79.9%
  • Biochemistry, Genetics and Molecular Biology13.5%
  • Materials Science2.8%
  • Engineering1%
  • Computer Science0.5%
  • Pharmacology, Toxicology and Pharmaceutics0.5%
  • その他1.8%

トピック

  • Chemotherapy-induced cardiotoxicity and mitigation18%
  • Cancer Treatment and Pharmacology7%
  • HER2/EGFR in Cancer Research5.9%
  • Breast Cancer Treatment Studies4.6%
  • Cardiac Imaging and Diagnostics2.8%
  • Lung Cancer Research Studies2.5%
  • その他59.2%

共著者

全論文

検索で開く
  1. Congestive heart failure in patients treated with doxorubicin

    著者: Sandra M. Swain, Fredrick S. Whaley, Michael S. Ewer - Cancer 2003 被引用: 2,284

  2. Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline

    著者: Saro H. Armenian, Christina Lacchetti, Ana Barac, Joseph R. Carver, Louis S. Constine, Neelima Denduluri, Susan Dent, Pamela S. Douglas, Jean‐Bernard Durand, Michael S. Ewer, Carol J. Fabian, Melissa M. Hudson, Mariell Jessup, Lee W. Jones, Bonnie Ky, Erica L. Mayer, Javid J. Moslehi, Kevin C. Oeffinger, Katharine Ray, Kathryn J. Ruddy, Daniel J. Lenihan - Journal of Clinical Oncology 2017 被引用: 1,263

  3. Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer in the APHINITY Trial: 6 Years' Follow-Up

    著者: Martine Piccart, Marion Procter, Debora Fumagalli, Evandro de Azambuja, Emma Clark, Michael S. Ewer, Eleonora Restuccia, Guy Jérusalem, Susan Dent, Linda Reaby, Hervé Bonnefoi, Ian E. Krop, Tsang‐Wu Liu, Tadeusz Pieńkowski, Masakazu Toi, Nicholas Wilcken, Michael Andersson, Young‐Hyuck Im, Ling‐Ming Tseng, Hans-Joachim Lueck, Marco Colleoni, Estefanía Monturus, Mihaela Sicoe, Sébastien Guillaume, José Bines, Richard D. Gelber, Giuseppe Viale, Christoph Thomssen - Journal of Clinical Oncology 2021 被引用: 359

  4. Expert Consensus for Multimodality Imaging Evaluation of Adult Patients during and after Cancer Therapy: A Report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

    著者: Juan Carlos Plana, Maurizio Galderisi, Ana Barac, Michael S. Ewer, Bonnie Ky, Marielle Scherrer‐Crosbie, Javier Gáname, Igal A. Sebag, Deborah A. Agler, Luigi P. Badano, José Banchs, Daniela Cardinale, Joseph R. Carver, M. Cerqueira, Jeanne M. DeCara, Thor Edvardsen, Scott D. Flamm, Thomas Force, Brian P. Griffin, Guy Jérusalem, J. E. Liu, Andreia Magalhães, Thomas H. Marwick, Liza Sanchez, Rosa Sicari, Hector R. Villarraga, Patrizio Lancellotti - European Heart Journal - Cardiovascular Imaging 2014 被引用: 1,783

  5. Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.

    著者: Sandra M. Swain, Fredrick S. Whaley, Mirjam C. Gerber, Stuart P. Weisberg, Michael York, Darcy Spicer, Sarah E. Jones, Scott Wadler, Anjali Desai, Charles L. Vogel, James L. Speyer, A Mittelman, Salitha Reddy, Kelly Pendergrass, E Vélez-García, Michael S. Ewer, J. R. Bianchine, Richard A. Gams - Journal of Clinical Oncology 1997 被引用: 652

  6. Cardiotoxicity of anticancer treatments

    著者: Michael S. Ewer, Steven M. Ewer - Nature Reviews Cardiology 2015 被引用: 414

  7. Erratum: Cardiotoxicity of anticancer treatments

    著者: Michael S. Ewer, Steven M. Ewer - Nature Reviews Cardiology 2015 被引用: 340

  8. Seven-Year Follow-Up Assessment of Cardiac Function in NSABP B-31, a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel (ACP) With ACP Plus Trastuzumab As Adjuvant Therapy for Patients With Node-Positive, Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

    著者: Edward H. Romond, Jong‐Hyeon Jeong, Priya Rastogi, Sandra M. Swain, Charles E. Geyer, Michael S. Ewer, Vikas Rathi, Louis Fehrenbacher, Adam Brufsky, Catherine A. Azar, Patrick J. Flynn, John L. Zapas, Jonathan Polikoff, Howard M. Gross, David D. Biggs, James N. Atkins, Elizabeth Tan-Chiu, Ping Zheng, Greg Yothers, Eleftherios P. Mamounas, Norman Wolmark - Journal of Clinical Oncology 2012 被引用: 519

  9. Pertuzumab, trastuzumab, and standard anthracycline- and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE): a phase II, open-label, multicenter, multinational cardiac safety study

    著者: Sandra M. Swain, Michael S. Ewer, Giuseppe Viale, Suzette Delaloge, Jean-­Marc Ferrero, Mark Verrill, Rámón Colomer, Cláudia Vieira, Theresa L. Werner, Hannah Douthwaite, Denise Bradley, Maeve Waldron-Lynch, Astrid Kiermaier, Jennifer Eng‐Wong, Chau T. Dang - Annals of Oncology 2017 被引用: 247

  10. Cardiovascular Complications of Cancer Therapy

    著者: Edward T.H. Yeh, Ann T. Tong, Daniel J. Lenihan, Salim Yusuf, Joseph Swafford, Christopher Champion, Jean‐Bernard Durand, Harry Gibbs, Alireza Atef Zafarmand, Michael S. Ewer - Circulation 2004 被引用: 851

  11. Reversibility of Trastuzumab-Related Cardiotoxicity: New Insights Based on Clinical Course and Response to Medical Treatment

    著者: Michael S. Ewer, Mary T. Vooletich, Jean‐Bernard Durand, Myrshia Woods, Joseph R. Davis, Vicente Valero, Daniel J. Lenihan - Journal of Clinical Oncology 2005 被引用: 727

  12. Cancer drugs and the heart: importance and management

    著者: Thomas Suter, Michael S. Ewer - European Heart Journal 2012 被引用: 472

  13. Cardiac Safety of Osimertinib: A Review of Data

    著者: Michael S. Ewer, Sri Harsha Tekumalla, Andrew Walding, Kwame N. Atuah - Journal of Clinical Oncology 2020 被引用: 87

  14. Cardiotoxicity of anticancer treatments: what the cardiologist needs to know

    著者: Michael S. Ewer, Steven M. Ewer - Nature Reviews Cardiology 2010 被引用: 372

  15. Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: NSABP B-31

    著者: Elizabeth Tan-Chiu, Greg Yothers, Edward H. Romond, Charles E. Geyer, Michael S. Ewer, Deborah Keefe, Richard P. Shannon, Sandra M. Swain, Ann Brown, Louis Fehrenbacher, Victor G. Vogel, Thomas E. Seay, Priya Rastogi, Eleftherios P. Mamounas, Norman Wolmark, John Bryant - Journal of Clinical Oncology 2005 被引用: 807

  16. Significantly Higher Pathologic Complete Remission Rate After Neoadjuvant Therapy With Trastuzumab, Paclitaxel, and Epirubicin Chemotherapy: Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer

    著者: Aman U. Buzdar, Nuhad K. Ibrahim, Deborah Francis, Daniel J. Booser, Eva Thomas, Richard L. Theriault, Lajos Pusztai, Marjorie C. Green, Banu Arun, Sharon H. Giordano, Massimo Cristofanilli, Debra Frye, Terry L. Smith, Kelly K. Hunt, S. Eva Singletary, Ayşegül A. Şahin, Michael S. Ewer, Thomas A. Buchholz, Donald A. Berry, Gabriel N. Hortobágyi - Journal of Clinical Oncology 2005 被引用: 1,170

  17. Type II Chemotherapy-Related Cardiac Dysfunction: Time to Recognize a New Entity

    著者: Michael S. Ewer, Scott M. Lippman - Journal of Clinical Oncology 2005 被引用: 646

  18. Anthracycline-induced cardiotoxicity and the cardiac-sparing effect of liposomal formulation.

    著者: Atiar M. Rahman, Syed Wamique Yusuf, Michael S. Ewer - 2007 被引用: 257

  19. Delayed administration of dexrazoxane provides cardioprotection for patients with advanced breast cancer treated with doxorubicin-containing therapy.

    著者: Sandra M. Swain, Fredrick S. Whaley, Mirjam C. Gerber, Michael S. Ewer, J. R. Bianchine, Richard A. Gams - Journal of Clinical Oncology 1997 被引用: 269

  20. Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis

    著者: Giuseppe Di Lorenzo, Riccardo Autorino, Gianni Bruni, Giacomo Cartenì, Enrico Ricevuto, Marianna Tudini, Corrado Ficorella, Carmela Romano, Michele Aieta, Antonio Giordano, Mario Giuliano, A. Gonnella, Cosimo De Nunzio, Mimma Rizzo, Vincenzo Montesarchio, Michael S. Ewer, Sabino De Placido - Annals of Oncology 2009 被引用: 205

  21. Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysis

    著者: Jennifer R. Brown, Javid J. Moslehi, Michael S. Ewer, Susan O’Brien, Paolo Ghia, Florence Cymbalista, Tait D. Shanafelt, Graeme Fraser, Simon Rule, Steven Coutré, Marie‐Sarah Dilhuydy, Paula Cramer, Ulrich Jaeger, Martin Dreyling, John C. Byrd, Steven P. Treon, Emily Y. Liu, Stephen Chang, Amulya Bista, Rama Vempati, Lisa Boornazian, Rudolph Valentino, Vijay Reddy, Michelle Mahler, Huiying Yang, Thorsten Graef, Jan A. Burger - British Journal of Haematology 2018 被引用: 90

  22. Cardiac safety of dual anti-HER2 blockade with pertuzumab plus trastuzumab in early HER2-positive breast cancer in the APHINITY trial

    著者: Evandro de Azambuja, Elisa Agostinetto, Marion Procter, Daniel Eiger, Noam Pondé, Sébastien Guillaume, Damien Parlier, Matteo Lambertini, A. Desmet, Carmela Caballero, Christian Águila, Guy Jérusalem, Janice M. Walshe, Erica Frank, José Bines, Sibylle Loibl, Martine Piccart, Michael S. Ewer, Susan Dent, Chris Plummer, Thomas Suter - ESMO Open 2023 被引用: 21

  23. Reduction of Doxorubicin Cardiotoxicity by Prolonged Continuous Intravenous Infusion

    著者: Sewa S. Legha, Robert S. Benjamin, Bruce R. MacKay, Michael S. Ewer, Sidney Wallace, Manuel Valdivieso, Shelley L. Rasmussen, George R. Blumenschein, Emil J. Freireich - Annals of Internal Medicine 1982 被引用: 769

  24. A comparison of cardiac biopsy grades and ejection fraction estimations in patients receiving Adriamycin.

    著者: Michael S. Ewer, Mohammed K. Ali, Brendan J. MacKay, Sophie Wallace, María González Valdivieso, Sapna Legha, Robert S. Benjamin, Thomas P. Haynie - Journal of Clinical Oncology 1984 被引用: 243